Glucomoringin
Glucomoringin, a structurally unusual glucosinolate found in seeds of Moringa oleifera Lam., is an antimicrobial agent. Glucomoringin permits to maximize it's power when bioactivated with myrosinase. Glucomoringin can be used for the research of bacterial infections.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 74542-19-1
- 화학식: C20H29NO14S2
- 분자량:571.57
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocol
- 순도&문서
- References
-
Help & FAQs
Biological Activity
제품 설명
In Vitro
Glucomoringin (1.52 mg/mL; 24 h) bioactivated to GMG-ITC potently inhibits the growth of Staphylococcus aureus subsp. aureus ATCC BAA-977 (inhibition halo of 25 mm) and Enterococcus casseliflavus ATCC 700327, shows no activity against Staphylococcus aureus ATCC BAA-1026, and does not inhibit Candida albicans ATCC 14053 growth in vitro[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 74542-19-1
-
분자량 571.57
-
화학식 C20H29NO14S2
-
SMILES
O[C@H]([C@@H]([C@H]([C@@H](O1)C)O)O)[C@@H]1OC(C=C2)=CC=C2C/C(S[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO)=N\OS(=O)(O)=O
-
Structure Classification
-
Initial Source
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Glucomoringin Related Classifications
HY-N19688 Related Classifications
Powered by Bioz
Keywords
- Glucomoringin
- 74542-19-1
- Bacterial
- Enterococcus casseliflavus
- Staphylococcus aureus subsp. aureus ATCC BAA-977
- Staphylococcus aureus BAA-977
- Staphylococcus aureus BAA-1026
- Candida albicans
- Enterococcus casseliflavus ATCC 700327
- 4-(α-L-rhamnosyloxy)benzyl isothiocyanate
- Moringa oleifera
- myrosinase
- nosocomial infections
- Inhibitor
- inhibitor
- inhibit